Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

730
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
730
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

612
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
612
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.2K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.2K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.3K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.3K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.9K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.9K
Pneumonia IV: Management01:28

Pneumonia IV: Management

1.0K
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ethanol-assisted fabrication of Casein-Ritonavir amorphous dispersions.

Food hydrocolloids for health·2026
Same author

RANQSAR: a standalone open-source application for reproducible machine learning-based QSAR analysis.

Journal of computer-aided molecular design·2026
Same author

Assessing Compliance of Tobacco Advertisement Promotions and Sponsorship Ban in India: Challenges, Opportunities, and the Way Forward.

Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine·2026
Same author

Exploring the terahertz absorption spectra of aqueous guanidinium chloride solutions using polarizable models for water and the salt.

Physical chemistry chemical physics : PCCP·2026
Same author

Folate receptor-α targeted therapies in ovarian cancer: recent advances and emerging therapeutic strategies.

International immunopharmacology·2026
Same author

Extracellular urate oxidase from Arthrobacter creatinolyticus SA1: statistical optimization, purification, and in-vitro evaluation of antihyperuricemic activity.

Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]·2026

Related Experiment Video

Updated: Mar 16, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.4K

Tuberculosis and its Treatment: An Overview.

Ranju Bansal1, Deepika Sharma1, Ranjit Singh1

  • 1University Institute of Pharmaceutical Sciences, Sector-14, Panjab University, Chandigarh-160014, India.

Mini Reviews in Medicinal Chemistry
|August 25, 2016
PubMed
Summary

Tuberculosis (TB) management is reviewed, covering standard and novel treatments for Mycobacterium tuberculosis. This includes drug resistance, DOTS strategy, and emerging therapies to combat TB globally.

Keywords:
BCGDOTSWHOisoniazidmycobacterium tuberculosispyrazinamiderifampicin

More Related Videos

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.3K
A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

8.4K

Related Experiment Videos

Last Updated: Mar 16, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.4K
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.3K
A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

8.4K

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Tuberculosis (TB) is a widespread infectious disease caused by Mycobacterium tuberculosis, affecting over a third of the global population.
  • Current TB treatment involves prolonged multi-antibiotic therapy, facing challenges from emerging antibiotic resistance, particularly in multidrug-resistant TB (MDR-TB).

Purpose of the Study:

  • To provide a comprehensive overview of TB management strategies.
  • To discuss first- and second-line anti-TB drugs, the DOTS strategy, and novel drug delivery systems.
  • To highlight new anti-TB drugs and vaccines in clinical development.

Main Methods:

  • Literature review of TB management.
  • Analysis of current and emerging anti-TB therapies.
  • Examination of drug delivery systems and vaccines for TB.

Main Results:

  • Detailed information on established anti-TB drugs and the WHO's DOTS strategy.
  • Exploration of novel drug delivery systems for improved efficacy.
  • Overview of advancements in new anti-TB drugs and vaccines.

Conclusions:

  • Comprehensive management of TB requires a multi-faceted approach, including effective drug regimens and novel strategies.
  • Addressing antibiotic resistance and advancing new treatments are crucial for global TB control.
  • Emerging drugs and vaccines show promise in combating Mycobacterium tuberculosis infections.